BSH 2024 Registration | British Society for Haematology ASM
Registration for BSH 2024 is now open! Our ASM takes place from 28-30 April 2024 in The ACC, Liverpool. Don’t miss out on our Early Bird fees!
Registration for BSH 2024 is now open! Our ASM takes place from 28-30 April 2024 in The ACC, Liverpool. Don’t miss out on our Early Bird fees!
The benefit of early palliative care in a resource-limited setting is not well understood. This study examined whether early palliative care could improve
Frontline eftilagimod alpha plus pembrolizumab generated responses in patients with recurrent or metastatic HNSCC with negative PD-L1 expression.
Overseeing the running of all aspects of the Society’s work, our Trustees are clinical experts with many years’ experience of working across all aspects of…
Cancer Gene Therapy – Mesenchymal stem cells as therapeutic vehicles for glioma
Here, we summarize a phase II study investigating the safety and efficacy of low-dose azacitidine + venetoclax as maintenance therapy in patients with acute myeloid…
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, discusses the potential for using measurable residual disease (MRD) status to…
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
The FDA has granted priority review to dostarlimab plus chemotherapy for all adult patients with primary advanced or recurrent endometrial cancer.
Kelly K. Hunt, MD, of The University of Texas MD Anderson Cancer Center, discusses the benefits to patients with neoadjuvant therapy in advanced, inoperable breast…